Evaxion - ROA 2020-2025 | EVAX

Current and historical return on assets (ROA) values for Evaxion - (EVAX) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Evaxion - ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2025-06-30 $-0.01B $0.02B -70.27%
2025-03-31 $-0.01B $0.03B -81.16%
2024-06-30 $-0.02B $0.02B -85.98%
2023-06-30 $-0.03B $0.02B -75.76%
2022-06-30 $-0.02B $0.03B -69.06%
2022-03-31 $-0.03B $0.04B -78.20%
2021-12-31 $-0.02B $0.04B -75.59%
2021-09-30 $-0.02B $0.02B -80.81%
2021-06-30 $-0.02B $0.03B -101.33%
2021-03-31 $-0.02B $0.04B -136.17%
2020-12-31 $-0.02B $0.01B -500.00%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.004B $0.003B
Evaxion A/S is a clinical-stage TechBio company specializing in developing AI-Immunology(TM) powered vaccines. Evaxion A/S, formerly known as Evaxion Biotech A/S, is based in COPENHAGEN, Denmark.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.466B 59.12
Tempus AI (TEM) United States $12.696B 0.00
Doximity (DOCS) United States $11.914B 53.01
Hims & Hers Health (HIMS) United States $9.534B 78.11
IRhythm Technologies (IRTC) United States $5.093B 0.00
Hinge Health (HNGE) United States $4.374B 0.00
Inspire Medical Systems (INSP) United States $2.663B 39.16
Privia Health (PRVA) United States $2.603B 192.82
Heartflow (HTFL) $2.489B 0.00
Enovis (ENOV) United States $1.740B 9.20
Phreesia (PHR) United States $1.681B 0.00
10x Genomics (TXG) United States $1.669B 0.00
Omnicell (OMCL) United States $1.466B 28.24
Schrodinger (SDGR) United States $1.428B 0.00
Azenta (AZTA) United States $1.388B 60.58
Clover Health Investments (CLOV) United States $1.292B 0.00
Claritev (CTEV) United States $1.115B 0.00
Evolent Health (EVH) United States $1.057B 0.00
Fulgent Genetics (FLGT) United States $0.660B 0.00
Zepp Health (ZEPP) Netherlands $0.568B 0.00
Veradigm (MDRX) United States $0.520B 0.00
Standard BioTools (LAB) United States $0.485B 0.00
Talkspace (TALK) United States $0.430B 128.50
Butterfly Network (BFLY) United States $0.347B 0.00
Carlsmed (CARL) $0.333B 0.00
TruBridge (TBRG) United States $0.293B 51.40
SOPHiA GENETICS SA (SOPH) Switzerland $0.237B 0.00
Outset Medical (OM) United States $0.237B 0.00
Nyxoah SA (NYXH) Belgium $0.214B 0.00
Health Catalyst (HCAT) United States $0.211B 0.00
KORU Medical Systems (KRMD) United States $0.190B 0.00
CapsoVision (CV) United States $0.182B 0.00
MDxHealth SA (MDXH) Belgium $0.137B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.119B 0.00
CareCloud (CCLD) United States $0.115B 5.23
American Well (AMWL) United States $0.115B 0.00
EUDA Health Holdings (EUDA) Singapore $0.086B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.074B 0.00
Pulmonx (LUNG) United States $0.062B 0.00
111 (YI) China $0.061B 0.00
P3 Health Partners (PIII) United States $0.052B 0.00
HeartBeam (BEAT) United States $0.038B 0.00
Zhongchao (ZCMD) China $0.024B 0.00
Precipio (PRPO) United States $0.023B 0.00
Healthcare Triangle (HCTI) United States $0.018B 0.00
Bullfrog AI Holdings (BFRG) United States $0.013B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
HeartSciences (HSCS) United States $0.008B 0.00
Strata Skin Sciences (SSKN) United States $0.008B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
Movano (MOVE) United States $0.004B 0.00
MSP Recovery (MSPR) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
PROFUSA (PFSA) United States $0.003B 0.00